Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-09-13
1997-09-23
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142342, 514263, 540575, 540600, 544118, 544267, 544271, 544272, C07D47312, C07D47310, C07D47306, A61K 3152
Patent
active
056704984
ABSTRACT:
Disclosed are xanthine derivatives represented by the following Formula (I): ##STR1## in which R.sup.1, R.sup.2, and R.sup.3 independently represent hydrogen or lower alkyl;
REFERENCES:
patent: 5270316 (1993-12-01), Suzuki
Papa, Eur. J. Pharmacology 232, 247 (1993).
Maj et al, J Neural Trans. 52, 189(1981).
Ossowska, Eur. J. Pharm. 182, 327 (1990).
"Pharm Basis of Therapeutics", 8th Edition (1990) pp. 406-407, 470-471.
Principles of Internal Medicine, vol. 2 (1991) p. 2060.
Jacobsen, J Med Chem 35, 407(1992).
Abstract for Larsen Tidsskrift for Den Narske Laege Forening 115(10) 1236-9 (1995).
Kaupp et al., Chem. Ber., vol. 119 (1986) 1525:39.
Erickson et al., J. Med. Chem., vol. 34, No. 4 (1991) 1431:35.
LU Govkin et al Chemical Abstracts, vol. 60, No. 38 (1964) 1741h.
Kase Hiroshi
Koike Nobuaki
Nakamura Joji
Nonaka Hiromi
Shimada Jun'ichi
Berch Mark L.
Kyowa Hakko Kogyo Co. Ltd.
LandOfFree
8-substituted styryl xanthine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-substituted styryl xanthine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-substituted styryl xanthine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938715